SARS COV-2

Clinical trials for SARS COV-2 explained in plain language.

Never miss a new study

Get alerted when new SARS COV-2 trials appear

Sign up with your email to follow new studies for SARS COV-2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 1 Not yet finished but already full! 9 Completed 32 Terminated 4

Could a common diabetes pill ease long COVID?

Disease control Not yet recruiting

This Phase 3 trial tests whether dapagliflozin, a drug used for diabetes, can improve quality of life in people with long COVID. 192 adults with persistent symptoms for at least 12 weeks after a COVID infection will receive either the drug or a placebo daily for 12 months. The ma…

Matched conditions: SARS COV-2

Phase: PHASE3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control

Last updated Jul 02, 2026 00:00 UTC

SARS COV-2

Get alerted when new SARS COV-2 trials appear

Could a common diabetes pill ease long COVID?